Alembic launches generic SolarazeGeneric Solaraze is a nonsteroidal anti-inflammatory drug indicated for the topical treatment of actinic keratoses. Samsung Bioepis, Organon obtain FDA nod for Humira biosimilarOrganon is expected to launch Hadlima on or after July 1, 2023. Walgreens takes on clinical trial business with new chief Ramita Tandon to lead Walgreens’ new clinical trial business and address diversity challenges. ANI obtains FDA OK for generic Decadron Dexamethasone is a type of corticosteroid used to treat several health conditions, including skin conditions, allergies, swelling and autoimmune conditions. Amphastar obtains FDA blessing for epinephrine pre-filled syringes Epinephrine injection is indicated to increase mean arterial blood pressure in adult patients with hypotension associated with septic shock. Hy-Vee pharmacies offering flu shots Flu vaccines are being offered at the retailer’s more than 270 pharmacy locations, with no appointment or prescription necessary. Alembic launches generic Doryx Generic Doryx should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. Roche obtains FDA nod for new indication of Xofluza Xofluza is the first and only single dose oral medicine for the treatment of influenza to be approved for children as young as 5 years old. 2022 NACDS Total Store Expo product showcase DSN has compiled a non-comprehensive list of companies and some of the new products on offer at this year’s NACDS TSE event. Amneal launches 4 generics Amneal’s generic Vasostrict, which is among the four new product introductions, expands the company’s injectables portfolio. First Previous 186 187 188 189 190 Next Last
